Abdominal Aortic Aneurysms and Pseudoexfoliation Syndrome

Hypertension Clinical Trial

Official title:

Abdominal Aortic Aneurysms Are Associated With Pseudoexfoliation Syndrome

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT00546013
• Other study ID #: 01
• Status: Terminated
• Phase: N/A
• First received: October 17, 2007
• Last updated: October 17, 2007
• Start date: December 2001
• Est. completion date: July 2002

Study information

• Verified date: October 2007
• Source: European Georges Pompidou Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: Institutional Ethical Committee
• Study type: Observational

Clinical Trial Summary

Conflicting results have been reported concerning the association of pseudoexfoliation syndrome (PXF) and abdominal aortic aneurysms (AAA). Schumacher et al. reported an association between AAA and PXF, with no consideration of grade. However, a later study did not confirm the association between AAA and PXF. The present study aimed at comparing the relative prevalence of PXF in patients suffering from AAA and in age-matched hypertensive patients.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 208
• Est. completion date: July 2002
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 60 Years and older

Eligibility

Inclusion Criteria:

• Presence of abdominal aortic aneurism

• Systemic hypertension without abdominal aortic aneurism over 60 years old

Exclusion Criteria:

• Unknown status for abdominal aortic aneurism

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Abdominal Aortic Aneurysms
• Aneurysm
• Aortic Aneurysm
• Aortic Aneurysm, Abdominal
• Exfoliation Syndrome
• Hypertension
• Pseudoexfoliation Syndrome
• Syndrome

Locations

Country	Name	City	State
France	Hôpital Européen Georges Pompidou	Paris

Sponsors (1)

Lead Sponsor	Collaborator
European Georges Pompidou Hospital

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	standard ophthalmologic examination to group patients according to their pseudoexfoliation status		Day of standard ophthalmologic examination